COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,693 Articles (22,913 medRxiv, 8,780 bioRxiv)

Most recent first Previous |  Page 1232: Articles 12311-12320  | Next

SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy
Ryu, J. K., Sozmen, E. G., Dixit, K., Montano, M., Matsui, Y., Liu, Y., Helmy, E., Deerinck, T. J., Yan, Z., Schuck, R., Acevedo, R. M., Spencer, C. M., Thomas, R., Pico, A. R., Zamvil, S. S., Lynch, K. L., Ellisman, M. H., Greene, W. C., Akassoglou, K.
10.1101/2021.10.12.464152 — Posted: 2021-10-13
Low antigen abundance limits efficient T-cell recognition of highly conserved regions of SARS-CoV-2
Swaminathan, S., Lineburg, K., Ambalathingal, G., Crooks, P., Grant, E., Mohan, S., Raju, J., Panikkar, A., Le Texier, L., Tong, Z., Chew, K., Neller, M., Gowda, H., Short, K., Gras, S., Smith, C., Khanna, R.
10.1101/2021.10.13.464181 — Posted: 2021-10-13
AUG-3387, a Human-Derived Monoclonal Antibody Neutralizes SARS-CoV-2 Variants and Reduces Viral Load from Therapeutic Treatment of Hamsters In Vivo
Emig, C. J., Mena, M. A., Henry, S. J., Vitug, A., Ventura, C. J., Fox, D., Nguyenla, X. H., Xu, H., Moon, C., Sahakijjpijarn, S., Kuehl, P. J., Revelli, D., Cui, Z., Williams, R. O., Christensen, D. J.
10.1101/2021.10.12.464150 — Posted: 2021-10-13
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
Greaney, A. J., Starr, T. N., Eguia, R. T., Loes, A. N., Khan, K., Karim, F., Cele, S., Bowen, J. E., Logue, J. K., Corti, D., Veesler, D., Chu, H. Y., Sigal, A., Bloom, J. D.
10.1101/2021.10.12.464114 — Posted: 2021-10-13
Genetically determined serum testosterone level and Covid-19 illness level: A mendelian randomization study
Xiong, J., Ma, Z., Miao, R., Huang, J., Kong, X.-J., Qu, Y., Yang, X.
10.1101/2021.10.10.21264779 — Posted: 2021-10-13
Heterologous SARS-CoV-2 Booster Vaccinations: Preliminary Report
Atmar, R. L., Lyke, K. E., Deming, M. E., Jackson, L. A., Branche, A. R., El Sahly, H. M., Rostad, C. A., Martin, J. M., Johnston, C., Rupp, R. E., Mulligan, M. J., Brady, R. C., Frenck, R. W., Backer, M., Kottkamp, A. C., Babu, T. M., Rajakumar, K., Edupuganti, S., Falsey, A. R., Posavad, C. M., Archer, J. I., Crandon, S., Nayak, S. U., Szydlo, D., Zemanek, J., Dominguez Islas, C. P., Brown, E. R., Suthar, M. S., McElrath, M. J., McDermott, A. B., O'Connell, S. E., Montefiori, D. C., Eaton, A., Neuzil, K. M., Stephens, D. S., Roberts, P. C., Beigel, J.
10.1101/2021.10.10.21264827 — Posted: 2021-10-13 Discussion: Onsite
An objective systematic comparison of the most common adverse events of COVID-19 vaccines
Behrens, C., Gasperazzo, T., Samii-Moghadam, M., Lampe, J. B.
10.1101/2021.10.11.21264830 — Posted: 2021-10-13
Child mental and behavioral health services during the COVID-19 pandemic: Trends and implications for service outcomes during telehealth expansion
Riley, E. N., Cordell, K., Shimshock, S., Lyons, J., Vsevolozhskaya, O. A.
10.1101/2021.10.10.21264817 — Posted: 2021-10-13
Modelling the effect of COVID-19 mass vaccination on acute admissions in a major English healthcare system
Booton, R. D., Powell, A. L., Turner, K. M., Wood, R. M.
10.1101/2021.10.10.21264821 — Posted: 2021-10-13
Effects of Age, Sex, Serostatus and Underlying Comorbidities on Humoral Response Post-SARS-CoV-2 Pfizer-BioNTech Vaccination: A Systematic Review
Notarte, K. I., Ver, A. T., Velasco, J. V., Pastrana, A., Catahay, J. A., Salvagno, G. L., Yap, E. P. H., Martinez-Sobrido, L., Torrelles, J., Lippi, G., Henry, B. M.
10.1101/2021.10.10.21264825 — Posted: 2021-10-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).